8-KEarnings & ResultsRegulation FDExhibits & Filings

CVS HEALTH Corp 8-K Report, Financial Results (Jan 4, 2018)

Filed January 4, 2018For Securities:CVS

Summary

CVS Health Corporation (CVS) filed an 8-K on January 4, 2018, to announce the revision of its fourth-quarter 2017 outlook and provide its full-year 2018 guidance. This filing is crucial for investors as it offers updated financial expectations and context surrounding the company's performance and future prospects. The press release attached provides the details of these financial updates, which are furnished and not filed, meaning they won't be automatically incorporated into future registration statements unless explicitly stated. The overarching theme of this filing, however, revolves around the "proposed transaction" with Aetna Inc. A significant portion of the document is dedicated to disclosures related to this merger, including information on "no offer or solicitation" and "additional information and where to find it." Investors should note that the company is urging them to read the forthcoming joint proxy statement/prospectus carefully, as it will contain vital information about the acquisition. This filing serves as a procedural update regarding the merger's progress and disclosure requirements.

Key Highlights

  • 1CVS Health revised its financial outlook for the fourth quarter of 2017.
  • 2The company also provided its financial guidance for the full year 2018.
  • 3The press release containing these updates was filed as Exhibit 99.1.
  • 4The information provided is furnished, not filed, with the SEC.
  • 5The filing extensively discusses the proposed acquisition of Aetna Inc.
  • 6CVS Health and Aetna will be filing a joint proxy statement/prospectus with the SEC.
  • 7Investors are strongly encouraged to review the upcoming joint proxy statement/prospectus for detailed information regarding the Aetna transaction.

Frequently Asked Questions

This 8-K filing primarily announces that CVS Health is revising its financial outlook for the fourth quarter of 2017 and issuing its guidance for the full year 2018. The specific details of these revised outlooks and guidance are presented in the press release attached as Exhibit 99.1.

The 'proposed transaction' refers to the acquisition of Aetna Inc. by CVS Health. A substantial portion of the filing is dedicated to disclosures and legal statements regarding this merger, including where investors can find more information and the roles of potential participants in the solicitation process.

Investors are urged to read the joint proxy statement/prospectus that CVS Health and Aetna will file with the SEC. This document will contain important information about the transaction. Free copies will be available on the SEC's website, and through CVS Health's and Aetna's investor relations departments and websites once they become available.

The information in Items 2.02 and 7.01, which includes the press release about financial outlook, is being 'furnished,' not 'filed,' with the SEC. This means it generally won't be automatically incorporated into CVS Health's registration statements unless specifically referenced.